leiomyoma. benign neoplasms of uterus with morphology code M889 and behaviour code /0
Conditions
Interventions
Intervention 1: Intervention group: Dcapeptyl 3/75 mg dose will injected intramuscularly in the gluteal region and by dorsogluteal pattern and deeply once every 28 days for 6 months (intervention o
Treatment - Drugs
Intervention group: Dcapeptyl 3/75 mg dose will injected intramuscularly in the gluteal region and by dorsogluteal pattern and deeply once every 28 days for 6 months (intervention on days 28, 56, 8
control group: control group will using Dydrogesterone 20mg from the 5th day of menstural cycle for 20 days.
Sponsors
Jahram University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: non menopausal wemon with myoma; not using another drugs; myoma has symptoms like pain and bleeding even with small size but large number. Exclusion criteria:menopausal women; using another drugs except decapeptyl for treatment; notsymptomatic myoma; allergic or intestinal reactions after getting drug.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lleiomyoma Size. Timepoint: Intervention on days 28, 56, 84, 112, 140 and 168 of the cycle. Method of measurement: mm. sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of myomectomy. Timepoint: End of study. Method of measurement: Enumeration. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAthar Rasekh Jahromi
Jahrom University of Medical Sciences
Outcome results
None listed